Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes.
Jetty A OverbeekEdith M HeintjesEline L HuismanChristian K TikkanenArnout W van DiermenFernie J A Penning-van BeestRon M C HeringsPublished in: Diabetes, obesity & metabolism (2018)
The results of this real-world study in matched obese patients with T2DM showed that liraglutide was more effective than BOT for HbA1c control and weight/BMI reductions. Patients were more likely to maintain glycaemic control over time after initiating liraglutide than after initiating BOT.
Keyphrases
- type diabetes
- weight loss
- body mass index
- end stage renal disease
- adipose tissue
- metabolic syndrome
- weight gain
- physical activity
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- newly diagnosed
- bariatric surgery
- glycemic control
- systematic review
- obese patients
- peritoneal dialysis
- body weight
- patient reported outcomes